HUTCHMED (China) Limited (HCM)
LSE
Closed
Oct 7, 2026
Day's Range
213.0052 wk Range
150.48Overview - HCM - HUTCHMED (China) Limited
Key Statistics
Valuation
Enterprise Value
460.07M
P/E (Trailing)
‪108.00‬
P/E (Forward)
‪20.79‬
PEG Ratio
‪20.79‬
Price / Sales (TTM)
‪3.41‬
Price / Book
‪199.30‬
EV / EBITDA
‪-29.70‬
Profitability
Gross Margin
‪23.08%‬
Profit Margin
‪3.25%‬
Operating Margin
‪0.31%‬
Return on Assets
‪-1.23%‬
Return on Equity
‪1.46%‬
Ownership
Shares Outstanding
859.74M
Float
522.84M
Held by Insiders
‪38.79%‬
Held by Institutions
‪19.84%‬
Price stats
Beta
‪0.44‬
50-Day Avg
‪188.28‬
200-Day Avg
‪195.92‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
6 analysts
Average price target
‪£ 327.21‬Market Cap - HCM - HUTCHMED (China) Limited
Peers - HCM - HUTCHMED (China) Limited
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on LSE.
- HCMLSEHUTCHMED (China) Limited187.71BMarket Cap-9.26%52-week change108.00P/E (Trailing)‪3.25%‬Profit Margin
- HLNLSEHaleon plc2.88TMarket Cap-1.07%52-week change18.76P/E (Trailing)‪14.55%‬Profit Margin
- 0QFPLSEGedeon Richter Plc.1.74TMarket Cap+0.00%52-week change7.34P/E (Trailing)‪19.72%‬Profit Margin
- HIKLSEHikma Pharmaceuticals PLC332.26BMarket Cap-8.04%52-week change12.41P/E (Trailing)‪11.31%‬Profit Margin
- ROSELSERosebank Industries plc308.38BMarket Cap-14.42%52-week change—P/E (Trailing)‪-4.92%‬Profit Margin
- 0MTDLSESwedish Orphan Biovitrum AB158.42BMarket Cap+36.33%52-week change45.80P/E (Trailing)‪15.54%‬Profit Margin
- 0O14LSEMerck KGaA62.53BMarket Cap+20.64%52-week change19.12P/E (Trailing)‪13.95%‬Profit Margin
Profile Summary - HCM - HUTCHMED (China) Limited
About
HUTCHMED (China) Limited is an innovative, commercial-stage biopharmaceutical company headquartered in Hong Kong, focused on the discovery, global development, and commercialization of targeted therapies and immunotherapies for cancer and immunological diseases. Established over two decades ago as one of China's first…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
